Top Stories in Cannabis Profits Daily
Executive Director Don Yocham had an important message for our Cannabis Profits Daily readers this week: “The stage is set and the time to be in cannabis is now.” That’s because he sees three unstoppable forces converging on the cannabis industry: surging revenues despite shut-downs, increased pressure to rapidly accelerate legalization, and a wave of profitability from some of the leading cannabis companies in the United States. But according to Don, this is just the start. Here’s what you need to know.
When someone buys stock in a business they don’t understand, Charlie Delvalle calls that gambling. And when a person buys a business they don’t understand and tries to run it? He calls that reckless endangerment of the financial kind. In part two of Charlie’s ongoing cannabis entrepreneurship series, he’s taking you through the specialized knowledge a cannabis entrepreneur needs to run a profitable dispensary. Because when it comes to cannabis investing, the more you know about the business side of things, the better equipped you are to make smart investing decisions. Read part two.
Did you know that May is “National Pet Month” in the U.S.? The popular pet supply store, PetSmart, sure knew – because just this month, it just announced that it is selling its first in-store hemp extract brand. The pet CBD market could reach $1.7 billion in the next few years, and this move by PetSmart will only accelerate the growth of the already unstoppable CBD market. Get the full story.
Last week, Don released an exclusive letter from Dr. Alan Shackelford for the National Institute for Cannabis Investors – “Honoring the Young Girl Who Showed Us the Potential of Medical Cannabis.” At great professional risk, Dr. Shackelford was the first to treat Charlotte Figi, the young girl who helped spark the CBD movement, with a cannabis strain high in CBD. Dr. Shackelford is working to continue Charlotte’s legacy to this day, and Don recently connected with Danny Brody to discuss just that. Watch the five-minute video.
Cannabis-based medicine has the potential to change the lives of countless people just like Charlotte.
And thanks to one company, the benefits of cannabis-based medicine could soon extend to those with multiple sclerosis (MS) and Parkinson’s disease.
Today, you have the opportunity to be a part of a life-changing medical breakthrough that could help millions of people…
A Once-in-a-Lifetime Chance to Make History
The global drug treatment market for MS alone could surpass $23 billion by 2025, according to some estimates.
So, if this company’s treatment is approved by the FDA, its proprietary synthetic cannabinoids could provide a cure to millions of people while also bringing early shareholders a piece of these multibillion-dollar markets.
In other words, by becoming an early investor in this pharma disruptor, you could “do well by doing good” – and make history while you’re at it.